Episode 14: Clinical Trial Challenges in the COVID-19 Pandemic

Podcast Item

A. Kate MacDougall

Nataya Francis, ARNP

As more and more clinical trials begin analyzing the novel SARS-CoV-2 virus and the efficacy and safety of potential treatment options, many of us are left wondering about how this shift in focus will affect ongoing and future clinical trials for other diseases, especially cancer. Nataya Francis, ARNP, nurse practitioner in the Clinical Research Unit at Moffitt Cancer Center, is seeing the impact on the oncology clinical trials management process firsthand.

Read our coverage on our Society website.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.